US Patent Issued to Beijing Neoletix Biological Technology on Aug. 19 for "Fusion protein of single domain antibody and procoagulant" (Georgia Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,754, issued on Aug. 19, was assigned to Beijing Neoletix Biological Technology Co. Ltd. (Beijing).

"Fusion protein of single domain antibody and procoagulant" was invented by Qi Li (Lawrenceville, Ga.) and Huafei Zou (Norcross, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to single domain antibodies (sdAbs) against TREM (triggering receptors expressed on myeloid cells) like transcript-1 (TLT-1) molecules that are present on activated platelets at the site of an injury, and especially on a subset of activated platelets, coated platelets. Furthermore, the present invention relates to fusion proteins comprising sdAbs...